randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als L-Carnitine in the Treatment Psychiatric and Neurological Manifestations: A Systematic Review Acetyl-l-carnitine versus placebo for migraine

Acetyl l carnitine versus placebo for migraine prophylaxis: A randomized, triple blind, crossover study Knut Hagen, Eiliv Brenner, Mattias Linde, Gril Bruvik Gravdahl, Erling Andreas Tronvik, Morten Engstrm, Ursula Sonnewald, Grethe Helde, Lars Jacob Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with Pharmacometabolomics applied to lowdose interleukin2 treatment in amyotrophic lateral sclerosis Alarcan 2024 Annals of the New York Academy of Sciences Wiley Online Library Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet

SKU: 4441455025 · From trustt.digital